NEW YORK (TheStreet) -- Shares of Imperva (IMPV) - Get Report were spiking 15% to $49.90 in pre-market trading on Friday as the company has received interest from companies such as Cisco Systems (CSCO) and IBM (IBM), Bloomberg reported, citing sources.

The Redwood City, CA-based cybersecurity software company hiredQatalyst Partners to launch a strategic review last month.

Forcepoint, which is jointly owned by private equity firms Vista Equity Partners and Raytheon, is also interested in buying the company, the sources added.

Bids are reportedly due in approximately two weeks, Bloomberg noted.

TST Recommends

Shares of Cisco and IBM are slightly lower in pre-market trading today.

Separately, TheStreet Ratings Team has a "Sell" rating with a score of D on Imperva stock.

The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and generally disappointing historical performance in the stock itself.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: IMPV

Image placeholder title